Cms grants additional reimbursement for exalt™ model d single-use duodenoscope

Marlborough, mass., aug. 2, 2021 /prnewswire/ -- boston scientific (nyse: bsx) announced that the u.s. centers for medicare & medicaid services (cms) granted a new technology add-on payment (ntap) for single-use duodenoscopes, applicable to the exalt™ model d single-use duodenoscope, as part of its fiscal year 2022 hospital inpatient prospective payment system.
BSX Ratings Summary
BSX Quant Ranking